Director · CATALYST PHARMACEUTICALS, INC. (CPRX)

Charles B. O'Keeffe director compensation at Catalyst (FY2024): $409K

Fiscal year 2024 director compensation for Charles B. O'Keeffe at CATALYST PHARMACEUTICALS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 11, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Charles B. O'Keeffe’s full pay file as a PDF — free

More than this page: up to 10 years of Charles’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Charles B. O'Keeffe and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

CATALYST PHARMACEUTICALS Director Compensation Table · all 2 fiscal years held
In US dollars, as CATALYST PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$59,750$0——$59,750
FY2024$108,625$300,019——$408,644

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CATALYST PHARMACEUTICALS, INC. DEF 14A filed April 11, 2025, accession 0001193125-25-079097, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CATALYST PHARMACEUTICALS, INC. filed document, accession 0001193125-25-079097. Every figure is read from that document and cited to the page and table it appears in. Filed April 11, 2025.

Get the CATALYST PHARMACEUTICALS Board Governance Report

$408,644 Charles B. O'Keeffe, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 11, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

CATALYST PHARMACEUTICALS pays directors a $60,000 cash retainer and $300,019 in Stock options and RSUs.

The rest of the CATALYST PHARMACEUTICALS board

FY2024 · as the company reported each
DirectorRoleFY2024 total
David S. TierneyIndependent Director$381,019
Donald A. DenkhausIndependent Director$386,269
Molly HarperLead Independent Director$439,144
Patrick J. McEnanyChair of the Board$844,759
Richard J. DalyDirector—
Tamar ThompsonIndependent Director$381,019

The full CATALYST PHARMACEUTICALS compensation record

free company brief

This page is one director within CATALYST PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Order CPRX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report